Skip to content
Screener

Geron GERN Operating Income

Operating Income at other companies

Incyte logo
IncyteINCY
$697.9M+31.6%
Immunome logo
ImmunomeIMNM
-$59.33M-32.9%
Exelixis logo
ExelixisEXEL
$248.41M+16.3%
CTO
Citius Oncology, Inc.CTOR
-$28.61M-283%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$336.6M+702%
Gilead Sciences logo
Gilead SciencesGILD
-$10.39B-520%

Other financials

Income statement

See full
Revenue$57.5M+17.2%
Net income-$16.7M-1.9%
EPS (diluted)-$0.020.0%

Balance sheet

See full
Cash & equivalents$64.5M-18.9%
Total debt$134.1M-0.3%
Total equity$218.6M-15.8%
Total assets$519.0M-6.5%

Cash flow

See full
Operating cash flow-$15.8M+42.3%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$1.01B+13.8%
Enterprise value$1.08B+14.5%
P/S4.9×-180×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-28.3%-2.3pp
Debt / equity0.6×+0.1×
Current ratio6.9×-1.0×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Geron’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:41 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000886744-26-000037
Line itemTHREE MONTHS ENDEDJUNE 30, 2026THREE MONTHS ENDEDJUNE 30, 2025SIX MONTHS ENDEDJUNE 30, 2026SIX MONTHS ENDEDJUNE 30, 2025
Selling, general and administrative38,86338,56474,28878,587
Restructuring charges(157)(551)
Total costs and operating expenses69,97661,490121,655117,797
Loss from operations(12,496)(12,454)(12,338)(29,158)
Interest income2,9714,6566,3929,808
Interest expense(7,146)(8,516)(14,293)(16,716)
Other income (expense), net(9)(61)(83)(144)
Net loss$(16,680)$(16,375)$(20,322)$(36,210)

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Geron's operating income?
Geron (GERN) reported operating income of -$12.5M in Q2 2026.
How has Geron's operating income changed year-over-year?
Geron's operating income decreased by 0.3% year-over-year, from -$12.45M to -$12.5M.
What is the long-term trend for Geron's operating income?
Over 4 years (2021 to 2025), Geron's operating income has grown at a -11.9% compound annual growth rate (CAGR), from -$114M to -$68.59M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Geron's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude